Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2026-02-12

FDA Approved: DIVIGEL — Supplemental Application (Vertical Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for DIVIGEL (estradiol) by Vertical Pharmaceuticals to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIVIGEL (Estradiol)

Snippet

SUPPL AP for DIVIGEL (ESTRADIOL)